Medicines Co. gets FDA approval of first patient-controlled patch for postoperative pain

The Medicines Company ($MDCO) scored two drug delivery feats on Friday. The FDA approved the company's Ionsys, making it the first patient-controlled patch for postoperative pain. In addition, the FDA approved the Medicine Company's Raplixa, the first spray powdered fibrin surgical sealant. More from FierceMedicalDevices